Herceptin
Trademark details
Herceptin® is a registered trademark used for Pharmaceutical Preparations For the Treatment of Cancer and owned by Genentech, Inc.. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Pharmaceutical Preparations For the Treatment of Cancer |
| Serial Number: | 74733146 |
| Registration Number: | 2157198 |
| Filing Date: | Sep 22, 1995 |
|
Last Applicant(s)/ Owner(s) of Record | Genentech, Inc.460 Point San Bruno Boulevard |
| Related Products: | Pharmaceuticals |
Suppliers

Total : 1 View more »
Genentech, Inc. in Sacramento, California, USA
Edit this Company edit this company Genentech, Inc. 980 9th St Ste 2180 Sacramento, California 95814-2716 USA tel: +1 9164435703 http://www.gene.com...
Web Sites
powered by 
Total : 2,020,000 View more »
HER2+ Breast Cancer Treatment with Herceptin® (trastuzumab)
Herceptin® (trastuzumab) is a HER2+ breast cancer therapy designed to treat aggressive HER positive metastatic and adjuvant breast cancer. BREAST CANCER INDICATIONS ...
Trastuzumab - Wikipedia, the free encyclopedia
Trastuzumab (INN ; trade name Herceptin) is a monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain breast cancers. The HER ...
Herceptin: Information from Answers.com
Herceptin Key Terms: Adjuvant therapy. Definition Herceptin is a medicine that is used to slow or stop the growth of a cancerous tumor
Herceptin Official FDA information, side effects and uses.
Accurate, FDA approved Herceptin information for healthcare professionals and patients - brought to you by Drugs.com.
Web Sites

Total : 117 View more »
Herceptin Now Approved In The EU For Patients With HER2-Positive Metastatic Gastric Cancer — Irish
...MIMS Ireland / New clinical evidence / Herceptin Now Approved In The EU For Patients...HER2-Positive Metastatic Gastric Cancer Herceptin Now Approved In The EU For Patients...Emmanuelle Pinjon Bookmark and Share herceptin_package_1_image1_1 Roche...
RxUSA Pharmacy, Prescriptions, Drugs, Medications, Pharmacy
...Casodex Cerezyme Generic Casodex Cytarabine Dacogen Doxil Emend Faslodex Fludara Gleevec Granisetron Herceptin Hycamtin Hydroxyurea Intron Kytril Methotrexate Mitomycin Mitoxantrone Mustargen Ondansetron Paclitaxel...
P&T Community
...therefore, guide optimum treatment. A history of biomarkers is included as well as a detailed discussion about trastuzumab (Herceptin®), developed with the support of biomarkers, and new biomarkers in development. Visit Formkit.com to view the newest...
Pittsburgh Tissue Engineering Initiative | Advancing Regenerative Medicine
Tissue Engineering, Regenerative Medicine Research, News and Education. PTEI has been a leader of the fast-growing sector of Regenerative Medicine and Tissue Engineering since 1996 with innovative programs in sponsored research and education that spur technology development and shape policy. PTEI
News and Blogs

Total : 660 View more »
Genentech's Herceptin Wins U.S. OK in Stomach Cancer -- Seeking Alpha
... Genentech's Herceptin Wins U.S. OK in Stomach Cancer ...diagnostic – Genentech Inc.'s targeted therapy Herceptin (trastuzumab...effective in those with HER2-positive disease, Herceptin's labeling requires patients...
Roche: novel Herceptin formulation promises greater convenience
...Bharat Book Logo Roche: novel Herceptin formulation promises greater convenience...leading breast cancer monoclonal antibody, Herceptin, Roche hopes to encourage uptake...Release) – Jun 11, 2010 – Roche: novel Herceptin formulation promises greater convenience...
Herceptin effective for gastric cancer, study finds | Australian Doctor
...Managing Diabetes Home/ News/ Herceptin effective for gastric cancer, study finds Herceptin effective for gastric cancer, study finds...to the breast cancer drug trastuzumab (Herceptin), research suggests. Testing...
Herceptin Prolongs Lives of Patients with HER2-positive Stomach Cancer | News | Drug Discovery and
...Subscriptions Log In Register News Herceptin Prolongs Lives of Patients with HER2-positive...international study which show that adding Herceptin (trastuzumab) to standard chemotherapy...Phase 3 trial investigating the benefit of Herceptin as a therapy for patients with advanced...
